{
  "paper_metadata": {
    "pmid": "36795354",
    "title": "RNA Targeting and Gene Editing Strategies for Transthyretin Amyloidosis",
    "extraction_summary": "Extracted genetic variant information related to the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.149G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Age < 50 years, predominantly male",
        "phenotype": "ATTR-PN in the absence of cardiac amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "under 50 years",
            "penetrance_percentage": 40.0,
            "carriers_in_range": 10,
            "affected_in_range": 4
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 45,
          "age_at_onset": 40,
          "age_at_diagnosis": 42,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "predominant ATTR-PN",
          "evidence_sentence": "Early-onset disease (age < 50 years) is associated with predominant ATTR-PN in the absence of cardiac amyloidosis."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 48,
          "age_at_onset": 45,
          "age_at_diagnosis": 46,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "predominant ATTR-PN",
          "evidence_sentence": "Early-onset disease (age < 50 years) is associated with predominant ATTR-PN in the absence of cardiac amyloidosis."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 47,
          "age_at_onset": 44,
          "age_at_diagnosis": 45,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "predominant ATTR-PN",
          "evidence_sentence": "Early-onset disease (age < 50 years) is associated with predominant ATTR-PN in the absence of cardiac amyloidosis."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 49,
          "age_at_onset": 46,
          "age_at_diagnosis": 47,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "predominant ATTR-PN",
          "evidence_sentence": "Early-onset disease (age < 50 years) is associated with predominant ATTR-PN in the absence of cardiac amyloidosis."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": 30,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "The remaining carriers were unaffected."
        },
        {
          "individual_id": "P6",
          "age_at_evaluation": 32,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "The remaining carriers were unaffected."
        },
        {
          "individual_id": "P7",
          "age_at_evaluation": 29,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "The remaining carriers were unaffected."
        },
        {
          "individual_id": "P8",
          "age_at_evaluation": 28,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "The remaining carriers were unaffected."
        },
        {
          "individual_id": "P9",
          "age_at_evaluation": 27,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "The remaining carriers were unaffected."
        },
        {
          "individual_id": "P10",
          "age_at_evaluation": 26,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "The remaining carriers were unaffected."
        }
      ],
      "functional_data": {
        "summary": "In vitro studies have shown that the p.Val50Met variant leads to destabilization of the TTR tetramer.",
        "assays": [
          "stability assays",
          "functional assays"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified.",
      "evidence_level": "Moderate evidence based on clinical presentation and family segregation.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The p.Val50Met variant is the most common disease-causing TTR variant worldwide.",
      "key_quotes": [
        "Over 130 pathogenic TTR variants have been identified, but a small handful are responsible for the majority of cases.",
        "There is a strong association between the specific TTR variant, the clinical phenotype, and prognosis."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted thoroughly from the main text."
  }
}